| Identification | |
| Name: | 3,5-Pyrazolidinedione,4-butyl-1-(4-hydroxyphenyl)-2-phenyl- |
| Synonyms: | 3,5-Pyrazolidinedione,4-butyl-1-(p-hydroxyphenyl)-2-phenyl- (6CI,7CI,8CI); 1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione;1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine;1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butylpyrazolidine;1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-n-butylpyrazolidine;4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine;4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,4-pyrazolidinedione;4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione; Butapirone;Californit; Crovaril; Flamaril; Floghene; Flogitolo; Flogoril; Frabel; G 27202;Metabolite I; NSC 526053; Neo-Farmadol; Offitril; Oxalid; Oxazolidin;Oxyphenbutazone; Oxyphenobutazone; Oxyphenylbutazone; Rapostan; Ro 04-4410;Romaxin; Suganril; Tandacote; Tandearil; Tanderil; Telidal; Tendearil;Visubutina; p-Hydroxyphenylbutazone; p-Oxyphenylbutazone |
| CAS: | 129-20-4 |
| EINECS: | 204-936-2 |
| Molecular Formula: | C19H20 N2 O3 |
| Molecular Weight: | 324.41 |
| InChI: | InChI=1/C19H20N2O3/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15/h4-8,10-13,17,22H,2-3,9H2,1H3 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 247.5°C |
| Boiling Point: | 485.6°Cat760mmHg |
| Density: | 1.241g/cm3 |
| Refractive index: | 1.61 |
| Solubility: | VERY SLIGHTLY SOL IN WATER; FREELY SOL IN ACETONE |
| Specification: |
Oxyphenbutazone ,its CAS NO. is 129-20-4,the synonyms is 1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione ; 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine ; 1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine ; 3,5-Dioxo-1-phenyl-2-(p-hydroxyphenyl)-4-N-butylpyrazolidene ; 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl ; 4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione ; Aradinum ; Artroflog ; Butapirone ; Californit ; Etrozolidina ; Flamaril ; Flegmostam ; Hydroxyphenylbutazon ; Idrobutazina ; Metabolite I ; Oxyphenbutazone anhydrous ; Oxyphenbutazonum ; p-Hydroxyphenylbutazone ; p-Oxyphenylbutazone . |
| Report: |
IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 , 1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 13 , 1977,p. 183.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . |
| Flash Point: | 247.5°C |
| Color: | WHITE TO YELLOWISH WHITE, CRYSTALLINE POWDER |
| Usage: | Anti-inflammatory |
| Safety Data | |
 |
|
